Literature DB >> 12208150

Amplification of extracellular nucleotide-induced leukocyte(s) degranulation by contingent autocrine and paracrine mode of leukotriene-mediated chemokine receptor activation.

S Kannan1.   

Abstract

Extracellular nucleotide-induced stimulation and activation of peripheral blood leukocytes and subsequent degranulation play a critical role in immediate-type hypersensitivity reaction and other inflammatory diseases. The extracellular nucleotides stimulate a P2Y receptor(s) on human PMN with the pharmacological profile similar to that of the P2Y2 receptor. Upon activation of P2Y2, arachidonic acid, formed from the membrane bound lipids by phospholipase A2, which subsequently metabolized by 5-lipoxygenase to form the leukotrienes. Of the several leukotrienes generated, LTB(4) is a potent pro-inflammatory chemokine. Upon its release LTB(4) binds to the PMN in a paracrine manner and also other leukocytes such as monocytes at the site of vascular injury, leading to an accelerated rate of degranulation. It is known that LTA(4) formed in the 5-lipoxygenase pathway in PMN could be released from PMN by receptor-mediated transport. Upon its release, the monocytes, erythrocytes, platelet, endothelial or smooth muscle cells can take up LTA(4). The endogenous LTA(4) hydrolase form the LTB(4) from LTA(4) in erythrocytes, platelet, endothelial or smooth muscle cells. As in PMN, LTB(4) is released from these cells via receptor-mediated transport to the extracellular milieu. Thus, released LTB(4) most likely acts as potentially accelerating factor in PMN and MN degranulation through its receptor-specific binding. It is not known whether any LTB(4) receptor exists in cytoplasm in any given cell type and also, the existence of any other signaling cascade for the extracellular nucleotide-induced leukocyte degranulation. Thus, it is convincing that the extracellular nucleotides released from the activated platelets and other damaged cell types exacerbate the inflammatory response by leukotriene generation. In turn the leukotriene will act in both autocrine and paracrine manner to amplify the degranulation processes in leukocytes invoked by extracellular nucleotides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208150     DOI: 10.1016/s0306-9877(02)00213-x

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  A chemoattractant-mediated Gi-coupled pathway activates adenylyl cyclase in human neutrophils.

Authors:  Dana C Mahadeo; Mirkka Janka-Junttila; Rory L Smoot; Pavla Roselova; Carole A Parent
Journal:  Mol Biol Cell       Date:  2006-11-29       Impact factor: 4.138

2.  LTB4 is a signal-relay molecule during neutrophil chemotaxis.

Authors:  Philippe V Afonso; Mirkka Janka-Junttila; Young Jong Lee; Colin P McCann; Charlotte M Oliver; Khaled A Aamer; Wolfgang Losert; Marcus T Cicerone; Carole A Parent
Journal:  Dev Cell       Date:  2012-04-26       Impact factor: 12.270

3.  4-thiouridine induces dose-dependent reduction of oedema, leucocyte influx and tumour necrosis factor in lung inflammation.

Authors:  C Evaldsson; I Rydén; A Rosén; S Uppugunduri
Journal:  Clin Exp Immunol       Date:  2008-12-01       Impact factor: 4.330

4.  Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection.

Authors:  Xiaohui Zhu; Yan Wang; Hongxing Zhang; Xuan Liu; Ting Chen; Ruifu Yang; Yuling Shi; Wuchun Cao; Ping Li; Qingjun Ma; Yun Zhai; Fuchu He; Gangqiao Zhou; Cheng Cao
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

Review 5.  Multiple Phenotypic Changes Define Neutrophil Priming.

Authors:  Irina Miralda; Silvia M Uriarte; Kenneth R McLeish
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

6.  Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes.

Authors:  Kristina Yeghiazaryan; Josef Flammer; Selim Orgül; Kerstin Wunderlich; Olga Golubnitschaja
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

7.  Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs.

Authors:  Kristina Yeghiazaryan; Josef Flammer; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.